香港股市 已收市

Torrent Pharmaceuticals Limited (TORNTPHARM.BO)

BSE - BSE 即時價格。貨幣為 INR。
加入追蹤清單
2,698.25-5.45 (-0.20%)
收市:03:29PM IST

Torrent Pharmaceuticals Limited

Torrent House
Off Ashram Road
Ahmedabad 380009
India
91 79 2659 9000
https://www.torrentpharma.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工13,247

高階主管

名稱頭銜支付行使價出生年份
Mr. Samir Uttamlal Mehta B.Com., MBAExecutive Chairman & MD230.04M1964
Mr. Jinesh Shah B.Sc., MBAExecutive Director of Operations & Whole Time Director58.87M1977
Mr. Aman MehtaWhole-Time Director20.59M
Mr. Sudhir Menon CA, CWAExecutive Director of Finance & CFO16.3M1972
Mr. Chintan TrivediCompany Secretary & Compliance Officer
Mr. Abdullah Salam Said Al AbriChief Customer Service Officer
Jaydip BhattVice President of Human Resource1953
Ashish Hajarnish M.PharmVice President of Works1968
Hasmukh Patel B.Pharm, M.Pharm.Vice President of Works1968
Kaushal Solanki CAVice President of Finance1967
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 INR。

描述

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

公司管治

截至 2024年5月1日 止,Torrent Pharmaceuticals Limited 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:3;董事會:8;股東權利:9;現金賠償:5。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。